Dicyclomine is an anticholinergic antispasmodic used for functional bowel and irritable bowel syndrome with painful intestinal cramping. It reduces gastrointestinal smooth muscle spasm but can cause clinically important anticholinergic adverse effects, especially in infants, older adults, glaucoma, urinary retention, and obstructive gastrointestinal disease.
Evidence rating strong. Most-documented uses: short-term relief of irritable bowel syndrome cramping, reduction of functional gastrointestinal smooth muscle spasm, adjunctive symptom control for abdominal pain related to bowel spasm. 3 sources indexed (2008–2026), with 4 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Dicyclomine antagonizes muscarinic acetylcholine receptors and also has a direct relaxant effect on gastrointestinal smooth muscle. Reduced parasympathetic tone decreases intestinal motility and spasm, which can improve cramping pain in irritable bowel syndrome. The same antimuscarinic activity can impair sweating, accommodation, bladder emptying, bowel transit, and cognition, explaining heat illness, blurred vision, constipation, urinary retention, tachycardia, confusion, and delirium risks.2,3
Class
Antimuscarinic antispasmodic
Dosing
Dosing & protocol.
Common range
Adults: usually 20 mg orally four times daily; may increase to 40 mg four times daily if tolerated. Discontinue if meaningful response is not achieved within 2 weeks or if adverse effects prevent use at effective doses.
Recommended form
Oral tablet, capsule, or solution; injectable forms are generally reserved for short-term supervised use
Oral doses may be taken with or without food. Separate from bulky fiber if symptoms or absorption concerns occur, and avoid alcohol or other sedatives when drowsiness is present.
Safety
Full safety detail.
Side effects
Dry mouth
Blurred vision
Constipation
Nausea
Dizziness
Drowsiness
Urinary retention
Tachycardia or palpitations
Confusion or delirium, especially in older adults
Heat intolerance or heat stroke from reduced sweating
Anticholinergic slowing of gastrointestinal transit may increase irritation risk from solid oral potassium products.
Recommendation: Use potassium only as directed by a clinician; liquid or divided formulations may be preferred when anticholinergic therapy is necessary.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
1
1Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysisNeeds reviewNo linkFord AC et al. · BMJ · 2008
Antispasmodic therapy showed benefit for global IBS symptoms, though adverse effects and study quality vary.
Reviews & position papers
1
2ACG Clinical Guideline: Management of Irritable Bowel SyndromeNeeds reviewNo linkLacy BE et al. · American Journal of Gastroenterology · 2021
Guideline emphasizes symptom-directed IBS therapy and careful adverse-effect consideration with antispasmodics.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Dicyclomine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.